Épisodes

  • S2 Ep11: How a Nurse's Question Changed Stem Cell Infusion Practice at UC Davis

    S2 Ep11: How a Nurse's Question Changed Stem Cell Infusion Practice at UC Davis
    Nov 11 2026
    When nurses at UC Davis Medical Center asked why stem cells were infused by gravity rather than by pump with filtered tubing, Jessica Miles, MS, RN, CNS, AOCNS, TCTCN, had no evidence-based answer. Her search for one became a nurse-driven quality improvement (QI) project, published in the Clinical Journal of Oncology Nursing, which found that peristaltic pumps and non–leukocyte-reducing filters did not compromise stem cell infusion safety.
    Afficher plus Afficher moins
    14 min
  • S2 Ep10: How Oncology Nurses Can Overcome Common Barriers to Research

    S2 Ep10: How Oncology Nurses Can Overcome Common Barriers to Research
    Oct 28 2026

    Oncology nurses who want to pursue research or evidence-based practice often face limited protected time, unexpected workloads, and slow approvals. For Leslie Smith, DNP, MSN, RN, APRN-CNS, BMTCN, AOCNS, the way forward starts with asking for help.

    “I just think, you know, reaching out is the first step,” Smith said on part 2 of an Onc Nurse On Call episode with Stephanie Desrosiers, DNP, MSN, RN, AOCNS, TCTCN, co-editor-in-chief of Oncology Nursing News and senior director of community-based ambulatory oncology nursing at UCLA Health.
    Afficher plus Afficher moins
    7 min
  • S2 Ep9: Patient Safety First: How a CNS Bridges Oncology Research and the Bedside

    S2 Ep9: Patient Safety First: How a CNS Bridges Oncology Research and the Bedside
    Oct 21 2026

    When a patient on a clinical trial deteriorates, bedside oncology nurses can feel caught between the protocol and the patient. For Leslie Smith, DNP, MSN, RN, APRN-CNS, BMTCN, AOCNS, the priority is clear.

    “The emphasis is always on the patient and safety. Research never outweighs the clinical care of the patient,” Smith said on part 1 of an Onc Nurse On Call episode with Stephanie Desrosiers, DNP, MSN, RN, AOCNS, TCTCN, co-editor-in-chief of Oncology Nursing News and senior director of community-based ambulatory oncology nursing at UCLA Health.
    Afficher plus Afficher moins
    9 min
  • S2 Ep8: Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

    S2 Ep8: Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management
    Oct 7 2026
    In this podcast, experts Emely Alfaro, DNP, RN, CNS, OCN, Marianne Davies, NP, DNP, MSN, APRN, BSN, and Stephanie McDonald, MSN, FNP-BC, AOCNP, discuss how to recognize, grade, and manage antibody-drug conjugate-associated toxicities.
    Afficher plus Afficher moins
    32 min
  • S2 Ep7: On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma

    S2 Ep7: On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma
    Sep 30 2026
    In the final installment of an Oncology Nursing News special three-part podcast series, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, of Cleveland Clinic, and Sikander Ailawadhi, MD, of Mayo Clinic, analyzed the institutional integration, clinical workflows, and future care models for subcutaneous isatuximab-irfc (Sarclisa Escena). The discussion followed the U.S. Food and Drug Administration (FDA) approval of isatuximab-irfc administered via the CirCLIQ on-body delivery system (OBDS) across all approved multiple myeloma indications.
    Afficher plus Afficher moins
    10 min
  • S2 Ep6: Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

    S2 Ep6: Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care
    Sep 25 2026
    In this podcast, experts Benjamin P. Levy, MD; Laura Alder, MD; and Beth Sandy, MSN, CRNP, FAPO, discuss biomarker testing for actionable genomic alterations in non–small cell lung cancer, management of ALK-positive advanced disease, and adjuvant targeted therapy for resectable disease.
    Afficher plus Afficher moins
    27 min
  • S2 Ep5: How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care

    S2 Ep5: How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care
    Sep 23 2026
    In the second episode of a special Oncology Nursing News podcast series, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, of Cleveland Clinic, and Sikander Ailawadhi, MD, of Mayo Clinic, discussed the structural innovations of on-body delivery systems in multiple myeloma care.
    Afficher plus Afficher moins
    8 min
  • S2 Ep4: Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma

    S2 Ep4: Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
    Sep 16 2026
    Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, of Cleveland Clinic, and Sikander Ailawadhi, MD, of Mayo Clinic, examine the transition toward automated on-body administration for multiple myeloma treatments. The discussion followed the U.S. Food and Drug Administration (FDA) approval of subcutaneous isatuximab-irfc (Sarclisa Escena) administered via the CirCLIQ on-body delivery system (OBDS) across all approved multiple myeloma indications.
    Afficher plus Afficher moins
    13 min